跳至主要内容
临床试验/NCT04096768
NCT04096768Unknown3 期

Combining Dexmedetomidine and Ketamine in Intensive Care Sedation: Efficacy and Safety

Lebanese American University Medical Center1 个研究点 分布在 1 个国家目标入组 394 人开始时间: 2019年9月16日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
发起方
入组人数
394
试验地点
1
主要终点
Measuring blood pressure to assess hypotension when using a combination of the two drugs for sedation versus Dexmedetomidine and placebo only

研究概览

简要总结

The aim of the study is to compare the use of dexmedetomidine + ketamine with dexmedetomidine + placebo for sedation in ICU patients in terms of safety and efficacy

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age between 18-80 years old
  • Admitted to Intensive care unit at LAUMCRH
  • Need for sedation for at least 24 hours
  • Informed Consent Form signed by patient or surrogate

排除标准

  • Pregnant patients
  • At risk of increased intracranial pressure
  • Aortic dissection
  • Acute coronary syndrome
  • Hypertension (SBP > 180 mmHg)
  • Chronic alcoholism
  • Acute alcohol intoxication
  • Alcohol withdrawal
  • Refractory status epilepticus
  • History of psychiatric disorder
  • Known allergy or contraindication to use of dexmedetomidine or ketamine
  • Baseline hypotension (MAP<65 mmHg)
  • Baseline bradycardia (HR<48 bpm)
  • Patients receiving neuromuscular blocking agents
  • Patients requiring deep sedation as determined by the ICU attending

研究组 & 干预措施

Dexmedetomidine + Ketamine

Experimental

干预措施: Dexmedetomidine (Drug)

Dexmedetomidine + Ketamine

Experimental

干预措施: Ketamine (Drug)

Dexmedetomidine + Placebo

Placebo Comparator

干预措施: Dexmedetomidine (Drug)

结局指标

主要结局

Measuring blood pressure to assess hypotension when using a combination of the two drugs for sedation versus Dexmedetomidine and placebo only

时间窗: Within 24 hours of drugs administration

Measuring blood pressure to assess hypotension when using a combination of the two drugs for sedation versus Dexmedetomidine and placebo only

次要结局

  • Measuring the doses of dexmedetomidine and ketamine when combined and the doses of dexmedetomidine when used alone to achieve desired level of sedation(Within 24 hours of drugs administration)

研究者

发起方
Lebanese American University Medical Center
申办方类型
Other
责任方
Principal Investigator
主要研究者

Fayez Abillama, MD

Intensive Care Medicine Physician

Lebanese American University Medical Center

研究点 (1)

Loading locations...

相似试验

The Use of Ketamine and Dexmedetomidine in Intensive... | 临床试验